Previous 10 | Next 10 |
Tennant Company (TNC) is expected to report for Q3 2023 Stellantis N.V. (STLA) is expected to report for Q3 2023 Marathon Petroleum Corporation (MPC) is expected to report $7.79 for Q3 2023 Easterly Government Properties Inc. (DEA) is expected to report $0.29 for Q3 2023 Allegion ...
Repligen Corporation (RGEN) is expected to report $0.14 for Q3 2023
2023-10-30 12:35:17 ET More on Repligen Repligen: Current Market Values Well Supported, Valuations Are Not, Reiterate Hold Repligen Corporation (RGEN) Q2 2023 Earnings Call Transcript Repligen beats bottom line, but misses topline Q2 estimates, lowers FY guidance ...
2023-10-30 12:28:25 ET More on Revvity Revvity: Recent Investments, Acquisitions, Not Pulling Economic Weight (Rating Downgrade) Revvity, Inc. (RVTY) Q2 2023 Earnings Call Transcript Revvity, Inc. 2023 Q2 - Results - Earnings Call Presentation Revvity misses ...
2023-10-25 13:15:34 ET More on Thermo Fisher Thermo Fisher Scientific Inc. (TMO) Q3 2023 Earnings Call Transcript Thermo Fisher Scientific: Too Big For Olink To Move The Needle Thermo Fisher Scientific: Transforming Healthcare Leadership Post-COVID-19 Pandemic ...
2023-10-24 10:21:05 ET More on Danaher Danaher Corporation 2023 Q3 - Results - Earnings Call Presentation Danaher: Short-Term Headwinds, But Long-Term Tailwinds Veralto: Thoughts On The Danaher Spinoff Danaher beats Q3 top-line and bottom-line estimates; init...
2023-10-24 09:46:03 ET More on MAIA Biotechnology Seeking Alpha’s Quant Rating on MAIA Biotechnology Historical earnings data for MAIA Biotechnology Financial information for MAIA Biotechnology For further details see: MAIA stock climbs on positive...
WALTHAM, Mass., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its third quarter 2023 financial results on Tuesday, October 31, 2023. The Company will issue a press release before the market opens and will host a conference call a...
2023-10-03 20:45:01 ET Summary Repligen Corporation's stock continues to track lower within its longer-term downtrend. Shares trade at 88x forward earnings, Q2 numbers were flat, and FY'23 guidance has been narrowed due to flat momentum. The company's economic value is low, an...
2023-10-03 17:46:09 ET More than 80 stocks were identified by Morgan Stanley as potentially having technical pressure due to tax loss selling. A Morgan Stanley U.S. Equity Strategy report, published on Monday, showed 81 stocks that could have performance pressures due to market selling ...
News, Short Squeeze, Breakout and More Instantly...
WALTHAM, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its second quarter 2024 financial results on Tuesday, July 30, 2024. The Company will issue a press release before the market opens and will host a conference call at ...
2024-07-04 04:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-21 14:00:08 ET Daniel Arias from Stifel Nicolaus issued a price target of $207.00 for RGEN on 2024-06-21 12:12:00. The adjusted price target was set to $207.00. At the time of the announcement, RGEN was trading at $123.16. The overall price target consensus is at...